Herlitz J, Hjalmarson A, Waldenström J
Acta Med Scand. 1984;216(3):261-7. doi: 10.1111/j.0954-6820.1984.tb03803.x.
In 585 patients with acute myocardial infarction (AMI) and no previous MI the maximal activity of serum heat-stable lactate dehydrogenase (LD) (EC 1.1.1.27) activity was related to 1-year and 2-year mortality rates. All patients participated in a double-blind trial with metoprolol during the first three months after an AMI. Thereafter both groups were treated in a similar way. A strong relationship was found between LD maximum activity and the in-hospital prognosis (p less than 0.001), the 1-year survival rate (p less than 0.001) and the 2-year survival rate (p less than 0.001). When the patients who were alive after primary hospitalization were analyzed as a separate group, the relationship between LD maximum activity and 1-year and 2-year survival rates remained (p less than 0.001). In a subsample of 171 patients the maximal activity of creatine kinase (CK) (EC 2.7.3.2) and CK subunit B did not correlate either with in-hospital, 1-year or 2-year survival rates. We conclude that, when a sufficiently large number of patients are investigated, there is a strong relationship between serum enzyme maximum activity and short- and long-term survival.
在585例急性心肌梗死(AMI)且既往无心肌梗死病史的患者中,血清热稳定乳酸脱氢酶(LD)(EC 1.1.1.27)的最大活性与1年和2年死亡率相关。所有患者在急性心肌梗死后的前三个月参加了一项美托洛尔双盲试验。此后,两组患者接受相似的治疗。发现LD最大活性与住院预后(p<0.001)、1年生存率(p<0.001)和2年生存率(p<0.001)之间存在密切关系。当将初次住院后存活的患者作为一个单独的组进行分析时,LD最大活性与1年和2年生存率之间的关系仍然存在(p<0.001)。在171例患者的子样本中,肌酸激酶(CK)(EC 2.7.3.2)和CK亚基B的最大活性与住院、1年或2年生存率均无相关性。我们得出结论,当对足够多的患者进行研究时,血清酶最大活性与短期和长期生存率之间存在密切关系。